HomeMDP • TSE
Medexus Pharmaceuticals Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 24.75M | -4.65% |
Operating expense | 15.08M | 27.06% |
Net income | -553.00K | -172.57% |
Net profit margin | -2.23 | -175.85% |
Earnings per share | -0.02 | -117.99% |
EBITDA | 2.10M | -49.01% |
Effective tax rate | 27.14% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 23.97M | 356.19% |
Total assets | 171.84M | 10.34% |
Total liabilities | 119.70M | -4.56% |
Total equity | 52.14M | — |
Shares outstanding | 32.26M | — |
Price to book | 1.81 | — |
Return on assets | -0.46% | — |
Return on capital | -0.89% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -553.00K | -172.57% |
Cash from operations | 2.28M | 41.63% |
Cash from investing | -2.06M | -283.46% |
Cash from financing | 15.17M | 482.98% |
Net change in cash | 15.53M | 625.08% |
Free cash flow | 14.47M | 2,706.10% |
Previous close
$2.94
Day range
$2.80 - $2.93
Year range
$1.71 - $5.56
Market cap
90.32M CAD
Avg Volume
38.91K
P/E ratio
24.11
Dividend yield
-
Primary exchange
TSE
About
Founded
2013
Headquarters
Website
Employees
91
